Lansoprazole prevents the progression of liver fibrosis in non‐alcoholic steatohepatitis model rats

E-ISSN： 2042-7158|70|3|383-392

ISSN： 0022-3573

Source： JOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Vol.70, Iss.3, 2018-03, pp. : 383-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Raman spectroscopy analysis of lipid droplets content, distribution and saturation level in Non‐Alcoholic Fatty Liver Disease in mice

JOURNAL OF BIOPHOTONICS (ELECTRONIC), Vol. 8, Iss. 7, 2015-07 ,pp. : 597-609

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fontan‐associated liver disease: Monitoring progression of liver fibrosis

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 11, Iss. 1, 2018-01 ,pp. : 1-5

John Wiley & Sons Inc

Access to resources Recommend Favorite

Future watch: Evolving trends in the management of nonalcoholic steatohepatitis

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 5, Iss. 6, 2015-06 ,pp. : 139-141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nootkatone confers hepatoprotective and anti‐fibrotic actions in a murine model of liver fibrosis by suppressing oxidative stress, inflammation, and apoptosis

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (FORMERLY JOURNAL OF BIOCHEMICAL TOXICOLOGY), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative proteomic analysis using 2DE‐LC‐MS/MS reveals the mechanism of Fuzhuan brick tea extract against hepatic fat accumulation in rats with nonalcoholic fatty liver disease

ELECTROPHORESIS, Vol. 36, Iss. 17, 2015-09 ,pp. : 2002-2016

John Wiley & Sons Inc

Access to resources Recommend Favorite